Colorectal Cancer
CDX2 useful as marker for colorectal adenocarcinoma
Published in Proteomics Weekly, December 20th, 2004
"CDX2 is a homeobox domain-containing transcription factor that is important in the development and differentiation of the intestines," pathologists in the United States explained. "Based on recent studies, CDX2 expression is immunohistochemically detectable in normal colonic enterocytes and is retained in most, but not all, colorectal adenocarcinomas."
"CDX2 expression has also been documented in a subset of adenocarcinomas arising in the stomach, esophagus and ovary," noted V. Kaimaktchiev and colleagues at the Oregon Health and Science University. In a recent study, they "examined CDX2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2004-12-20)
More Articles from Proteomics Weekly
- Atherosclerosis
Lipoprotein induction of chemotactic protein-3 in atherosclerosis - Epilepsy
Overexpressed neuropeptide Y may protect against hyperexcitability - Infection
HCMV induces rapamycin-insensitive phosphorylation of mTOR kinase effectors - Osteoarthritis
Collagen synthesis, regulatory molecule expression studied in osteoarthritis - Pediatrics
A protein in breast milk helps prevent and treat deadly neonatal enterocolitis - Physiology
Integrin-mediated cellular functions selectively inactivated - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
